{"name":"Digestive & Liver Disease Specialists","slug":"digestive-liver-disease-specialists","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Antacids","genericName":"Antacids","slug":"antacids","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Antacids","genericName":"Antacids","slug":"antacids","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTFBmNGNManRwWjVfVTFBanVkUjZqZHZubzNjOS1PaFlIMWtmUHc3a2hWT1IyWi1mMmFwQkNCN1JrRDlSNVlheVZYVkdPd19TanBJVm5mMVE3cGxvUjdITjlmOFRvTHRFb1o1VlBsTXBZTQ?oc=5","date":"2026-01-13","type":"pipeline","source":"ScienceDaily","summary":"Doctors discover the source of mysterious intoxication - ScienceDaily","headline":"Doctors discover the source of mysterious intoxication","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxQZ2FfTzdtM3dLLWZSUmZXR0t4bjZGTnZTRkdJdk51M21lcC1rbzl1eTEyeDlQWTBRTmdsc01mVlVTX3BIOGxzb2FoT0pZRV9jeDRLX3NPUWgtOGtNTVNCOXdiMUtIZjJCTWo3WFFJeTBCQVVCaDlWOE9DSTZlbnJ2QW9wX3c3a0RyTFlGTWVCTGVUV2hxNGlUQlk2SmQwNHFzYWVvMVRmZGpIYlBrYy04VF9XRy1QQlZzR2tfdGNpTl9Vb0U0ODNycFB2WUYyS0JPN3NwNTUzVDhtQzRPOHdmb0ZobEtmS2ZIdVhjbU9kdnRFLW42TkRnVk9tS2Z2Ni1GbUxoeXBFYWZtWEhid1FjSlJnZVF3STFRNGF3NmJZX1dRVmt1ZlhmbTJuNDFrdEprRkR5QU5B?oc=5","date":"2025-11-07","type":"trial","source":"Business Wire","summary":"Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical Programs at AASLD’s The Liver Meeting® - Business Wire","headline":"Mirum Pharmaceuticals Showcases Leadership in Liver Disease Innovation With Data From LIVMARLI® and Volixibat Clinical P","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNSDBLSmE3bUhoT0FENFNuVTlpa09lZE0xbWE3TnJzNzNROG56RGpoT3VaX1NlZFhRRk90eDJGVVNSQXdVSXhKSEhkazMxNlRCcThmRkwwTW1SbEN4LWxucTR3S3VhTl82QXFibE1UY0hiZEh0aGVONVhXLURTOU5RcERzdkhnc3FyUXE5WWxOSmlheTJldy1BQXlGMkFEUHBKakZ2RThLSUliVVg5bEEyY3RKM2E?oc=5","date":"2025-11-06","type":"pipeline","source":"NewYork-Presbyterian","summary":"Dr. Braden Kuo Named Chief of Division of Digestive and Liver Diseases at NewYork-Presbyterian and Columbia - NewYork-Presbyterian","headline":"Dr. Braden Kuo Named Chief of Division of Digestive and Liver Diseases at NewYork-Presbyterian and Columbia - NewYork","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE94LTVfdi1GbkozUDBXNzVHdnZFM1BrNTB3a0pfc1VVWWZWdFdpdWVyeHMxSjA1TDUzUUZXQ1NrNHJtZTZRZlRzbzFfSzdqSFFKYi11cnFJQlhFWnh3eVhDQkQyZDgyU2pVTHJvLQ?oc=5","date":"2025-04-17","type":"pipeline","source":"Time Magazine","summary":"How a New Weight-Loss Pill Could Transform Health - Time Magazine","headline":"How a New Weight-Loss Pill Could Transform Health","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPdV9LTkl0Y0czWGhYODd1S3o4VXRhYURob3JXZ20waW03Q3c0bV93SHNORWJwVG8zd2pOdDF4ZXE5VUVXaDdIWFRicVFjZHFJdDdWTzBCMGhYZ0xMajBGZXI0SlkwNUhYN25rd2lySHRuZ1JYbEFNVHlTNmh1c1N6ejNrTTd4NHpuUTltOW16ekVIakNkMUJVRG9BVUJnOHNIUDEtQzlGV2FWeFNuRlBtVUdYbXQtdEIwR3g4N2JmSWxjb2RXOHBR?oc=5","date":"2024-10-08","type":"regulatory","source":"Boehringer Ingelheim","summary":"Survodutide US FDA Breakthrough Therapy phase 3 trials MASH - Boehringer Ingelheim","headline":"Survodutide US FDA Breakthrough Therapy phase 3 trials MASH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQMVFwQWdfUkY5anRLTHFpSkpVbEFKNmhxT190TFVSejFJeHNzcFZzMjBOTUhHYUxSN3Fka3F3aWkwaVBfd2U4bG5BSEFnM2gwamx1YVRBSGExaUJLQXF5WUlDbUw3ckxuOXM3WG5KYnBtT241bWtWSEw3dUlpSVJvMTAwdFFON21N?oc=5","date":"2024-03-24","type":"regulatory","source":"Yale Medicine","summary":"FDA Approves Rezdiffra, the First Drug for NASH, a Form of Fatty Liver Disease | News - Yale Medicine","headline":"FDA Approves Rezdiffra, the First Drug for NASH, a Form of Fatty Liver Disease | News","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPWWNxenZ0NVpEb1BjSWJxT2FKSEZJYnVyNGZpZTJ3eWJBQnZnYXhJWlJERVlPVk5sSm1ZS05mWlh2aTVtQk1ZdVAyYmpWU3ZxLWJHMFowckVsN1NZLUVMY0habUVOWkRmNDdDckVXUEYtU003STJJcGpGLUJmRDZRaEVJZm9zTXBtWjZFMnNNTnlQaWJQX0kxT1ZHMThmeHgwcW5jYkQ0cDg?oc=5","date":"2024-03-06","type":"pipeline","source":"UChicago Medicine","summary":"New drug shows promise for liver disease - UChicago Medicine","headline":"New drug shows promise for liver disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOaDBRMVNqNXFFV1E2VzVLLWxlLTVyVG16YkFZT1JuYy1sSTFMaWVmaDhqR0VIU2w4bl9UMHpZMVVpR092MFFROHdPMkNLZy1xX1lHa04zNUN6RzE1eHB5MFFPT2hGcVFXNllwLUVOVExOMTBoTmJHQVV1ZkoxR1ZKU0lSOXA5NTZ2U01ZQmRpZFZHc1lzQVpNTmNlemlvb25fcjZ3SVdVRDUydkNkNEFxYWZGcUR5bTI5V3VBVFBtSGtoMXhvZE12a1o2MGdmV2dJY0E3MGdidllaNEQ5U0NyclVPdw?oc=5","date":"2023-11-01","type":"pipeline","source":"Florida Hospital News and Healthcare Report","summary":"Tampa General Hospital Digestive Health Center Offers Updated Screenings for Nonalcoholic Fatty Liver Disease - Florida Hospital News and Healthcare Report","headline":"Tampa General Hospital Digestive Health Center Offers Updated Screenings for Nonalcoholic Fatty Liver Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBnaGR3aU95d2xFRzUyVnBGWXdrbzRSdk00Q0pQRlVEVWE2cnhTWUxVRzJXMmRVb0RvMndaQnJ5OW5XUUJ0RHdsTWtqUHpBX1lGdHNLRFRSQktLVURCMFk0TWFKZ0lYN09DcEdSNWV2Mmo?oc=5","date":"2023-05-22","type":"pipeline","source":"Takeda Pharmaceuticals","summary":"Therapeutic Focus - Gastrointestinal and Inflammation - Takeda Pharmaceuticals","headline":"Therapeutic Focus - Gastrointestinal and Inflammation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQYUhQWnhDMER6dlVqbXNtWnVuZnl4MjEtbHBvTXE2aFpQc3llR3ktOF9xbWd6R0N6MVJJNG0xWWEtQUFHdXVyaXdSVTlmdVUxcmQ5WTQwS09hcDJmSnB3ODNVRGc4a1JVTHF2U21uMkhZSnJyM1VpdXFRaWNrYW1xeHlZQ01fX09aV0drbS1qQUJfUjZxWkdiWHlMTW1YQWRCR2R2SVRiS1NiRzZjd1RtQmxTanVYbGRjNWtWUFc2aw?oc=5","date":"2023-05-12","type":"trial","source":"Fierce Pharma","summary":"Liver disease misinformation rampant on TikTok: study - Fierce Pharma","headline":"Liver disease misinformation rampant on TikTok: study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPenlrbmZEZ25NVmZ3UDBIQXQzLW9QaW1mZXRKUG5hbV9kOUdUclJuT25sQzlLckZjUGhRSnoybFk0MkdxUnFyay13MmdkV0hXaURlZXh3M281VVNHVFVDVWlWM3lsams2UjZqUGhXWUJpaHg3d21uNkVsaDltT2RSblNxeXJndVdERkFFQzRSX0QwUQ?oc=5","date":"2020-04-27","type":"pipeline","source":"Frontiers","summary":"Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathophysiological and Pharmaceutical Factors - Frontiers","headline":"Advances in Oral Drug Delivery for Regional Targeting in the Gastrointestinal Tract - Influence of Physiological, Pathop","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPbWZSMy0tVWRiTVN1VnJxRlVtQTQtNnczdXV2bjF0OHVFZk5KVzhLUUlGckoxUVlOamlHUEJ6bG43akdvdy15ZXhHTmtXakVkOVRFZ21rSnRiRkN1RTcwUzM1M1prSTFlMDRVT3BraXd4T2tJdUcxTmItaU1XSXdZRXJ0UE9GdVk0dHBmNU9RUldhN0VWb0dGb2NIQjlYRTZzRlR2WnFZbTNBNzJnNkFveE8wcnd1SF9mMnNwQURHalF0eGFpQk5Ka0JlZkVVQW1LQkhCNHBOUThBWkRxeUxUelB1Z1V2MVhRVE5jTHhoTQ?oc=5","date":"2019-05-14","type":"trial","source":"prnewswire.com","summary":"Salix Pharmaceuticals Marks 30-Year Anniversary With Largest Showing Of Data At Digestive Disease Week - prnewswire.com","headline":"Salix Pharmaceuticals Marks 30-Year Anniversary With Largest Showing Of Data At Digestive Disease Week","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}